Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Cytotherapy ; 10(2): 182-92, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18368597

RESUMO

BACKGROUND: In patients transplanted with cord blood (CB), prolonged thrombocytopenia is a major complication. However, this could be alleviated by supplementing the CB graft with ex vivo-expanded megakaryocytic progenitors (CFU-Meg), provided that the homing properties of these cells are not affected negatively by expansion. METHODS AND RESULTS: We assessed the in vitro homing potential of CFU-Meg progenitors expanded from CB and showed that the combination of thrombopoietin (TPO) with interleukin-3 (IL-3) used for expansion not only results in optimal proliferation of CFU-Meg but also protects these cells from apoptosis. Moreover, we found that ex vivo-expanded CFU-Meg maintained expression of the CXCR4 receptor throughout a 9-day culture and were chemoattracted towards a stromal cell-derived factor-1 (SDF-1) gradient. They also expressed matrix metalloproteinase-9 (MMP-9) and membrane-type (MT) 1-MMP, and transmigrated across the reconstituted basement membrane Matrigel. Finally, we observed that SDF-1 up-regulated the expression of both MMP-9 and MT1-MMP in CB CD34(+) cells and ex vivo-expanded CFU-Meg. DISCUSSION: We suggest that CB-expanded CFU-Meg, in particular those from day 3 of expansion, when their proliferation and in vitro homing potential are maximal, could be employed to supplement CB grafts and speed up platelet recovery in transplant recipients.


Assuntos
Ensaio de Unidades Formadoras de Colônias , Sangue Fetal/citologia , Sangue Fetal/enzimologia , Metaloproteinase 14 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Megacariócitos/citologia , Células-Tronco/citologia , Antígenos CD34/metabolismo , Catequina/análogos & derivados , Catequina/farmacologia , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Quimiocina CXCL12/metabolismo , Fatores Quimiotáticos/farmacologia , Quimiotaxia/efeitos dos fármacos , Colágeno/metabolismo , Combinação de Medicamentos , Sangue Fetal/efeitos dos fármacos , Humanos , Interleucina-3/farmacologia , Cinética , Laminina/metabolismo , Metaloproteinase 14 da Matriz/genética , Metaloproteinase 9 da Matriz/genética , Megacariócitos/efeitos dos fármacos , Megacariócitos/enzimologia , Glicoproteína IIb da Membrana de Plaquetas/metabolismo , Proteoglicanas/metabolismo , Receptores CXCR4/metabolismo , Células-Tronco/efeitos dos fármacos , Trombopoetina/farmacologia , Regulação para Cima/efeitos dos fármacos
2.
Magn Reson Med ; 3(2): 203-16, 1986 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3713486

RESUMO

31P nuclear magnetic resonance spectroscopy has been used to study freshly aspirated normal human bone marrow samples. The pH within the intact cells of the samples was determined from the chemical-shift position of the resonance for inorganic phosphate within the cell; the intracellular pH was found to be 7.35 for fresh bone marrow. The chemical-shift positions of the alpha and beta phosphate resonances of adenosine 5'-triphosphate were used to assess the fraction of this metabolite complexed with Mg2+. It was found that 84% of the total intracellular adenosine 5'-triphosphate was in the Mg2+-complexed form. The concentration of Mg2+ uncomplexed to any ligand was 0.4 mM. The areas of the resonances for the major phosphorus-containing metabolites were used to determine intracellular concentrations. For fresh human bone marrow, the intracellular concentrations determined were phosphate monoesters less than 0.3 mM, 2,3-diphosphoglycerate 3.9 +/- 1.0 mM, inorganic phosphate 1.2 +/- 0.6 mM, phosphodiesters 2.8 +/- 1.0 mM, adenosine 5'-triphosphate 1.6 +/- 0.4 mM, adenosine 5-diphosphate less than 0.2 mM, and nicotinamide adenine dinucleotide less than 0.2 mM. These metabolite concentrations within the intact cell samples did not change over 2.0 h and changed only gradually over a 24-h period. 31P nuclear magnetic resonance spectroscopy was then used to study the cryopreservation of normal human bone marrow in the presence of increasing concentrations of the penetrating cryopreservative dimethyl sulfoxide. Dimethyl sulfoxide alone without freezing was found to cause some gradual hydrolysis of 2,3-diphosphoglycerate, presumably by stimulating diphosphoglycerate phosphatase. The effect of freezing human bone marrow to liquid nitrogen temperatures, storage, and rapid thawing was a dramatic fall in intracellular adenosine 5'-triphosphate levels. The half-life of the metabolite, after thawing, was about 0.3 h. If the bone marrow was frozen in the presence of 2.5, 5.0, and 7.5% dimethyl sulfoxide, the post-thaw half-life was prolonged to 0.4, 0.5, and 0.6 h, respectively. 15% dimethyl sulfoxide afforded complete cryoprotection, with adenosine 5'-triphosphate levels constant for 15 h after thawing the human bone marrow.


Assuntos
Medula Óssea/efeitos dos fármacos , Dimetil Sulfóxido/farmacologia , Espectroscopia de Ressonância Magnética , 2,3-Difosfoglicerato , Monofosfato de Adenosina/análise , Trifosfato de Adenosina/análise , Medula Óssea/análise , Ácidos Difosfoglicéricos/análise , Congelamento , Meia-Vida , Humanos , Concentração de Íons de Hidrogênio , Fosfatos/análise , Fósforo , Análise Espectral , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA